Scientists hunt for hidden antibodies in severe seizure disorders
NCT ID NCT04421846
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collects blood, spinal fluid, and brain tissue from 400 people with severe seizures (status epilepticus) or epilepsy linked to brain inflammation (dysimmune encephalitis), plus control patients. Researchers aim to find antibodies and markers of nerve cell death that could improve diagnosis and understanding of these serious conditions. Participants must be 2 years or older and enrolled in French social security.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSIMMUNE ENCEPHALITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital de la Pitié Salpêtrière
RECRUITINGParis, 75013, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain wave battle: deeper suppression may halt post-arrest seizures
- Seizure drug may shield the brain after cardiac arrest — a trial puts it to the test
- Brain rescue: dual drug attack on Post-Arrest seizures shows promise
- Can a half-day training sharpen ICU nurses' ability to detect hidden seizures?
- Life after a seizure emergency: study tracks hidden toll on mind and body
- Massive brain injury study aims to unlock secrets of recovery